Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

8C5806D9A188BEDA8725851300829A54 Hearing Summary




PUBLIC
BILL SUMMARY For HB20-1065

HOUSE COMMITTEE ON HEALTH & INSURANCE
Date Feb 19, 2020      
Location HCR 0112



HB20-1065 - Amended, referred to House Appropriations

04:46:38 PM  

Representative Kennedy and Representative Herod, bill sponsors, presented House Bill 20-1065 to the committee.  The bill requires health insurers to reimburse hospitals for prescribing opiate antagonists to covered individuals; creates immunity for individuals who administer an expired antagonist; allows pharmacists to sell non-prescribed clean syringes or needles to individuals without a prescription; allows local public health agencies to operate clean syringe programs without county approval and allows hospitals to operate a clean syringe program; and increases appropriations to the Harm Reduction Grant Program Cash Fund.



A handout was distributed (Attachment O).  Amendments L.001 and L.002 were distributed to the committee (Attachments P and Q).

04:54:40 PM  

The bill sponsors responded to committee questions.

04:55:33 PM  

Representative Caraveo proceeded with witness testimony on the bill.

04:57:15 PM  

Dr. Joyce Gamewell, representing herself, testified in opposition to the bill and distributed a handout (Attachment R).  Longinos Gonzalez, El Paso County Commissioner, testified in opposition to the bill.  Helen Collins, representing herself, testified in opposition to the bill.  The witness panel responded to committee questions.

05:10:59 PM  

Dr. Rob Valuck, Colorado Consortium for Prescription Drug Abuse Prevention, testified in support of the bill.  Jessica Kobylinski, Colorado Health Network, testified in support of the bill.  Lisa Raville, Harm Reduction Action Center, testified in support of the bill.  Dr. Judy Solano, Southern Colorado Harm Reduction, testified in support of the bill.

05:35:48 PM  

The previous panel of witnesses responded to questions from the committee.

05:39:53 PM  

Dr. Chris Stock, Colorado Consortium for Prescription Drug Abuse Prevention, testified in support of the bill.  Tracey Ritter, representing herself, testified in support of the bill.  Dr. Sarah Rowan, Denver Public Health, testified in support of the bill.  Jackie Zheleznyak, Denver Health, testified in support of the bill and distributed a handout (Attachment S).  The witness panel responded to committee questions.

05:58:33 PM  

Paul Glasheen, representing himself, testified in support of the bill.  David Wasserman, representing himself, testified in support of the bill.

06:05:46 PM  

The bill sponsors discussed amendments to the bill.



06:09:29 PM
Motion Adopt amendment L.001 (Attachment P).
Moved Mullica
Seconded Titone
Baisley
Buckner Excused
Champion
Jackson
Mullica
Soper
Tipper
Titone
Will
Caraveo
Lontine
YES: 0   NO: 0   EXC: 1   ABS:  0   FINAL ACTION:  Pass Without Objection


06:10:17 PM
Motion Adopt amendment L.002 (Attachment Q).
Moved Mullica
Seconded Titone
Baisley
Buckner Excused
Champion
Jackson
Mullica
Soper
Tipper
Titone
Will
Caraveo
Lontine
YES: 0   NO: 0   EXC: 1   ABS:  0   FINAL ACTION:  Pass Without Objection
06:10:19 PM  
The bill sponsors gave closing remarks on the bill. Committee members commented on the bill.


06:20:52 PM
Motion Refer House Bill 20-1065, as amended, to the Committee on Appropriations.
Moved Mullica
Seconded Jackson
Baisley No
Buckner Excused
Champion No
Jackson Yes
Mullica Yes
Soper No
Tipper Yes
Titone Yes
Will No
Caraveo Yes
Lontine Yes
Final YES: 6   NO: 4   EXC: 1   ABS:  0   FINAL ACTION:  PASS






Colorado legislature email addresses ending in @state.co.us are no longer active. Please replace @state.co.us with @coleg.gov for Colorado legislature email addresses. Details

The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details